# Platelet Reactivity With Fentanyl, Morphine, or no Narcotic

> **NCT05367336** · PHASE2 · TERMINATED · sponsor: **Corewell Health South** · enrollment: 21 (actual)

## Conditions studied

- Fentanyl
- Platelet Reactivity

## Interventions

- **DRUG:** Morphine
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT05367336
- **Lead sponsor:** Corewell Health South
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-31
- **Primary completion:** 2025-02-18
- **Final completion:** 2025-02-18
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** The study was halted prematurely due to difficulties in recruiting a sufficient number of participants. Despite efforts to enroll eligible individuals, the recruitment goals were not met, making it infeasible to continue the study as planned.
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05367336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05367336, "Platelet Reactivity With Fentanyl, Morphine, or no Narcotic". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05367336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*